SOURCE: Leerink Swann & Company

February 01, 2007 07:00 ET

Michael Weintraub Joins Leerink Swann as Senior Managing Director to Head Corporate Development & Strategy

BOSTON, MA -- (MARKET WIRE) -- February 1, 2007 --Leerink Swann & Company announced Michael Weintraub joined the firm as Senior Managing Director and Head of Corporate Development & Strategy. Mr. Weintraub's background includes 25 years of executive management experience in the healthcare technology, information services and consulting arenas. Mr. Weintraub holds a B.A. in economics from Brandeis University and an MBA from Harvard Business School.

"I am delighted to have Michael Weintraub join the firm as the member of our executive team to head our corporate development and strategy agenda," said Jeffrey A. Leerink, Chairman and CEO of Leerink Swann. "In this capacity, Michael will lead Leerink Swann's knowledge-ware initiatives including MEDACorp and its network of physician consultants. A veteran Healthcare Information Technology (HCIT) executive, Michael also will work closely with Leerink Swann's investment banking team to launch the firm's HCIT advisory and banking services. His skill in developing knowledge-based businesses in the healthcare arena will be a tremendous asset to our platform as we build a premier healthcare investment banking firm."

"The world class talent within Leerink Swann, the loyalty of the firm's customers, and the valuable insights from the MEDACorp consultant network provide a unique and exciting opportunity moving forward," stated Michael Weintraub. "By sitting at the critical intersection of how healthcare innovation is financed and ultimately delivered to the consumer, the firm is positioned to enable the effective and efficient capitalization and financing of these vital healthcare solutions."

Mr. Weintraub was President and CEO of PharMetrics from 2001 to 2006. PharMetrics provided healthcare business-intelligence information solutions to firms across the spectrum of the healthcare field and was acquired by IMS Health in July 2005.

In addition, he has held senior leadership positions in several start-up and rapid growth, health care information technology organizations. Mr. Weintraub was Chief Operating Officer of eLoyalty, a premier customer relationship management firm spun out from Technology Solutions Company. Prior to that, he was Vice President & General Manager at The MEDSTAT Group, now part of Thomson, Senior Vice President & Officer at MediQual Systems, which was acquired by Cardinal Health, and a Director at Amherst Associates, which was acquired by McKesson/ HBOC.

About Leerink Swann & Company

Leerink Swann & Company is an investment banking firm that provides healthcare equity research, corporate finance, and asset management services for institutional and high-net-worth clients. Leerink Swann & Company was voted the Best Firm in Biotechnology, Health Care Technology & Distribution, Medical Supplies and Devices, Pharmaceuticals/Major, and Pharmaceuticals/Specialty in the 2006 Institutional Investor poll ranking the best boutique and regional firms by sector. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. Through its internal team of experts and its dedicated external network of academic and community healthcare professionals, MEDACorp assesses the viability of cutting-edge medical technologies, thus giving decision makers the information they need to perform. Leerink Swann & Company is a member NASD/SIPC.

Contact Information

  • Contact:
    John I. Fitzgerald
    Leerink Swann & Company
    (617) 918-4564